[1]
“EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES”, RMSR, vol. 3, no. 5, pp. 290–294, May 2025, Accessed: May 14, 2025. [Online]. Available: http://thermsr.com/index.php/Journal/article/view/1109